statement
At the investor day, management highlighted AI-driven drug discovery (AIDD) as an emerging structural growth driver.
A statement by 管理層. Statements are as reported by the cited publishers — not verified by DecisionGateway.
管理層在投資者日重點介紹了人工智能驅動藥物發現(AIDD)作為新興的結構性增長驅動力
Discussion
Related claims
Nikkei's Global Management Dialogue will explore AI's new paths to growth.nikkeiasia · statementAIDD will expand demand for early-stage CRO.報告 · predictionPrice corrections and industry demand changes must be observed separately; given Taiwan tech industry's supply chain position and corporate profit performance, AI remains an important driver of medium- to long-term growth.張雅雯 · statementAI投資與變現面臨再評價,金融市場波動加大。里歐 · statementHIVE's AI business grew.HIVE · statementThe AI growth trend remains unchanged, but the market now places more weight on profit growth percentage.post author · statement